Olorinab (APD371), a peripherally acting, highly selective, full agonist of the cannabinoid receptor 2, reduces colitis-induced acute and chronic visceral hypersensitivity in rodents.
Journal Information
Full Title: Pain
Abbreviation: Pain
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Psychophysiology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article."
"Medical writing support was provided by ApotheCom (San Francisco, CA) and was funded by Arena Pharmaceuticals. S.M. Brierley was supported by a National Health and Medical Research Council of Australia (NHMRC) R.D. Wright Biomedical Research Fellowship (APP1126378) and by NHMRC Australia Project Grants (APP1139366 and APP1140297). J. Castro is funded by an NHMRC Australia Ideas Grant (APP1181448). A.M. Harrington is funded by an ARC Discovery Project (DP180101395)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025